MedPath

A Randomised Controlled Trial to Investigate the Effects of a Mindfulness Smartphone App on Well-being in the Workplace

Not Applicable
Conditions
Well-being, Work Stress
Interventions
Other: Headspace On-the-go app
Registration Number
NCT01661569
Lead Sponsor
University College, London
Brief Summary

We propose a randomised controlled trial in a workplace setting to investigate whether a smartphone-delivered programme of mindfulness meditation influences psychological and biological indicators of well-being.

We hypothesise that after 8 weeks participants who complete the meditation programme will show increases in psychological well-being and reduced activation of stress-related biological pathways.

Detailed Description

Mindfulness-based therapies can reduce depressive symptoms in patients and healthy subjects. Therapies such as MBSR (mindfulness-based stress reduction) typically consist of 8 group sessions led by an experienced practitioner, plus home practice and one full day of meditation. In this study we aim to investigate whether a mindfulness programme delivered as a series of podcasts on a mobile phone app could lead to gains in well-being and a reduction in stress.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Employees of a UK high-tech company
  • Raised levels of work stress (overcommitment>2) or depression (CESD>1)
Exclusion Criteria
  • treated for anxiety, depression or hypertension
  • taking medication containing steroids

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Headspace On-the-go appHeadspace On-the-go appParticipants were given access to a 45-day mindfulness meditation programme via the Headspace smartphone app
Primary Outcome Measures
NameTimeMethod
Well-being8 weeks

Psychological well-being will be assessed using the Warwick Edinburgh Mental Well-Being Scale

Secondary Outcome Measures
NameTimeMethod
Blood pressure8 weeks

Blood pressure over the working day will be measured as an indicator of activation of the stress response

Trial Locations

Locations (1)

UK high-tech company office

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath